Lupin Pharmaceuticals Inc. recalls Glucagon Emergency Kit for Low Blood Sugar
- Recalling company
- Lupin Pharmaceuticals Inc.
- Product
- Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection USP, 1mg per vial, Diluent for Glucagon, 1 mL syringe, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur - 441108, INDIA, NDC 70748-311-01
- Reason
- CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Jun 23, 2026
- Reported
- Jul 8, 2026
- Distribution
- Nationwide within the U.S.
- Status
- Ongoing
- Quantity
- 64,894 units
- Lot / codes
- Kit Lots: WB00010, Exp. Date Jan 2027; WB00017, WB00019, Exp. Date Feb 2027; WB00070, Exp. Date Jun 2027; WB00077, WB00078, Exp. Date Jul 2027; WB00130, Exp. Date Nov 2027.
- Company location
- Naples, FL
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0723-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0723-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.